← Leaderboards
Hyacinth Idu Hyacinth
University Of Cincinnati
$13,234,033
Attributed
$13,234,033
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,234,033 · 4
By mechanism
R01$12,788,533 · 3
R21$445,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Edward C Jauch$2,263,428
- Joan M Cook-Mills$17,204,943
- Jiukuan Hao$3,084,464
- Achala Sameer Vagal$6,346,822
- Pooja Khatri$21,577,634
Others in their field
Other Emerging Leaders on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Greg Yothers · University Of Chicago$35,003,821
- Anthony Philippakis · University Of California Santa Cruz$30,961,549
Research focus
BrainImageMagnetic Resonance ImagingStrokeImmunohistochemistrySickle Cell AnemiaSickle CellReportingAge Of OnsetBone MarrowBlood VesselsLifeCerebral InfarctionChildMediatingCerebrumPrevention StrategyLaser Scanning MicroscopyPreventionSeveritiesMagnetic Resonance AngiographyInfarctionAdultProspective
Grant awards (22)
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimerâs disease and its related dementias$1,006,548
R01 · FY2025 · AG · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$834,942
R01 · FY2025 · HL · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$235,090
R01 · FY2025 · HL · contact PI
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimerâs disease and its related dementias$1,233,404
R01 · FY2024 · AG · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$591,381
R01 · FY2024 · HL · contact PI
Interaction of sickle cell trait with human apolipoprotein E ε4: Impact on brain structure, brain lipidomics, neuroinflammation and cognitive deficit$445,500
R21 · FY2024 · AG · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$235,090
R01 · FY2024 · HL · contact PI
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimerâs disease and its related dementias$1,205,269
R01 · FY2023 · AG · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$610,214
R01 · FY2023 · HL · contact PI
Sickle cell disease and the functional circuit of adult-born neurons in the dentate gyrus$235,090
R01 · FY2023 · HL · contact PI
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimerâs disease and its related dementias$1,385,735
R01 · FY2022 · AG · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$631,946
R01 · FY2022 · HL · contact PI
Cerebral small vessel disease burden and racial disparity in vascular cognitive impairment and Alzheimerâs disease and its related dementias$1,505,134
R01 · FY2021 · AG · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$405,000
R01 · FY2021 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$405,000
R01 · FY2021 · HL · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$327,919
R01 · FY2021 · HL · contact PI
Minocycline as a potential therapy for neuroinflammation and cognitive deficit in sickle cell disease$286,061
R01 · FY2021 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$454,480
R01 · FY2020 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$30,230
R01 · FY2020 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$390,000
R01 · FY2019 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$390,000
R01 · FY2018 · HL · contact PI
Mechanism of cerebral vaculopathy and stroke in sickle cell disease$390,000
R01 · FY2017 · HL · contact PI